KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
155 hedge funds and large institutions have $1.49B invested in Chinook Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
3% more funds holding
Funds holding: 151 → 155 (+4)
Holders
155
Holding in Top 10
8
Calls
$969K
Puts
$316K
Top Buyers
| 1 | +$19.7M | |
| 2 | +$18.9M | |
| 3 | +$13.6M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$12.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
Top Sellers
| 1 | -$30.7M | |
| 2 | -$14.2M | |
| 3 | -$10.7M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$6.01M |
| 5 |
HM
HealthCor Management
New York
|
-$5.42M |